Reps per District???

Discussion in 'Boehringer Ingelheim' started by anonymous, Apr 19, 2016 at 1:54 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Even with those numbers, be prepared for more cuts for resp. in the future. Look at the $ sales for IPF. 4-5 TIMES higher than resp. Look how many reps they have in the nation, about 100 give or take. Resp. is completely and totally doomed.
     

  2. anonymous

    anonymous Guest

    Sounds possible but I'm not leaving without severance $
     
  3. anonymous

    anonymous Guest

    Yeah and to top that off with ipf lincare accounted for 90% of ofev sales. Now they are out of the picture the future is unknown with the low life expectancy with that disease
     
  4. anonymous

    anonymous Guest

    does anyone know how many of the Resp territories are manned by Ashfield vs. BI? I am legacy BI and want to gauge my prospects moving forward, have a family to protect
     
  5. anonymous

    anonymous Guest

    If you were part of this company you would know that. Go away troll!!
     
  6. anonymous

    anonymous Guest

    Relax Francis, I call valid query to poster...
     
  7. anonymous

    anonymous Guest


    That's because you're the same person!!!
     
  8. anonymous

    anonymous Guest

    you are both losers for bickering. Try ~450 territories for resp, and ~500 for diabetes. 1 rep per territory for resp, 245 overlays plus 1 per territory for diabetes. Give or take a dozen territories when this all settles. Bottom line, is that Resp got a huge haircut, and Diabetes some pruning of dead wood, but essentially a boost for Jardiance CV indication. No specialists anymore. No CSC's pretending to be specialists.
     
  9. anonymous

    anonymous Guest

    Resp is probably about 300 BI, 150 Ashfield, and ALL placements moving forward will be Ashfield. There may be an opportunity for an Ashfield RESP overlay force (like diabetes at 245) but that got tabled for later this year. Diabetes and Diabetes overlay has some Ashfield embedded but nothing like Respiratory. The failure of STIOLTO totally sealed the fate of the legacy BI resp force.
     
  10. anonymous

    anonymous Guest

    Hard to believe that resp is that low, and now most Ashfield
     
  11. anonymous

    anonymous Guest

     
  12. anonymous

    anonymous Guest

    Ok, you need to pay me for that kind of Intel.
     
  13. anonymous

    anonymous Guest

    Its amazing to me how many people fail to look at the big picture. This industry is incredibly incestuous, it functions like a bunch of lemmings all reacting pathetically late to obvious trends in pharma that even the lamest rep stumbling around in a haze could see. Just look at what Merck did last year if you want to view your future, all PC products shoved in one bag, massive rep layoffs and a reduction in managers of 50%+. With managed care dominating what ultimately gets prescribed and dwindling physician access ,(which by the way, only gets worse as reps methodically piss off the few remaining open offices by dragging in their overpaid babysitter manager in every other week) it’s a wonder this job still even exists . Better buckle up baby! Because this deli-slinging cushy pharma gig is about to hit some big ass pot holes
     
  14. anonymous

    anonymous Guest

    So funny and so true! There is zero need for 50% of the professional baby sitters and their useless diaper filling districts
    Big changes a coming - just wait. Gonna be a blue Christmas
     
  15. anonymous

    anonymous Guest

    And this company is always about 2 years behind the curve.
     
  16. anonymous

    anonymous Guest

    Thus, we’ll be ok until 2 Christmases from now.